Cansino Biologics Inc.
Clinical trials sponsored by Cansino Biologics Inc., explained in plain language.
A vaccine company developing and manufacturing vaccines, including for COVID-19.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Vaccine Follow-Up: how long does protection last in babies?
Knowledge-focused Not yet recruitingThis study follows 100 infants who received a pneumococcal vaccine in an earlier trial. Researchers will take a small blood sample to measure antibody levels one and two years after vaccination. The goal is to see how long protection against pneumococcal infections lasts. No new …
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Will a single DTP vaccine dose protect for a decade? study tracks antibodies
Knowledge-focused Not yet recruitingThis study follows 160 people who previously received a 5-component DTP vaccine (protecting against diphtheria, tetanus, and pertussis) to see how long their immune protection lasts. Blood samples are taken at 2.5, 5, and 10 years after vaccination to measure antibody levels. The…
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could a single meningitis shot protect for years? a study investigates
Knowledge-focused Not yet recruitingThis study follows 180 children who received a meningitis vaccine (ACYW135 conjugate) years ago to see if their immune protection lasts. Researchers will measure antibody levels in blood samples taken 3 and 5 years after vaccination. The goal is to understand how long immunity pe…
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC